Lilly’s Bio-Medicines Portfolio Grows To Offset Pressures In Key Markets

Where Rebates Eat Into Prices, Volume Makes Up The Difference

 
• By Mandy Jackson
  
Pressure meter or indicator
With pressure growing in areas like psoriasis, Lilly Bio-Medicines is expanding into other inflammatory diseases like ulcerative colitis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business